About Perfuze
Perfuze is a company based in Galway (Ireland) founded in 2018. Perfuze has raised $53.17 million across 5 funding rounds from investors including EQT, European Commission and Enterprise Ireland. Perfuze offers products and services including Millipede 088 Catheter. Perfuze operates in a competitive market with competitors including Conformal Medical, MIVI Neuroscience, MicroTransponder, Wallaby Medical and Enspire DBS Therapy, among others.
- Headquarter Galway, Ireland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Perfuze Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$53.17 M (USD)
in 5 rounds
-
Latest Funding Round
$23.98 M (USD), Series A
Mar 13, 2025
-
Investors
EQT
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Perfuze
Perfuze offers a comprehensive portfolio of products and services, including Millipede 088 Catheter.
Catheter for removing clots in ischemic stroke patients.
Funding Insights of Perfuze
Perfuze has successfully raised a total of $53.17M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $23.98 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Perfuze
Perfuze has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include EQT, European Commission and Enterprise Ireland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
|
Locked | Locked | Locked | |
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
Seroba Lifesciences is focused on life sciences venture capital investments.
|
Locked | Locked | Locked |
Investor details for Perfuze
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Perfuze
Investment portfolio details for Perfuze
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Perfuze
Detailed financials for Perfuze
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Perfuze Comparisons
Peer comparison for Perfuze
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Perfuze
Perfuze operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conformal Medical, MIVI Neuroscience, MicroTransponder, Wallaby Medical and Enspire DBS Therapy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stroke prevention device for atrial fibrillation patients is developed.
|
|
| Locked | Locked | Locked |
Catheters and devices for acute ischemic stroke treatment are developed.
|
|
| Locked | Locked | Locked |
Neurostimulation for chronic pain management, tinnitus treatment and post-stroke rehabilitation
|
|
| Locked | Locked | Locked |
A medical device for stroke treatment is developed.
|
|
| Locked | Locked | Locked |
Stroke recovery therapy is developed via deep brain stimulation.
|
Detailed competitors of Perfuze
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Perfuze
Complete news archive for Perfuze
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Perfuze
Perfuze was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Perfuze is headquartered in Galway, Ireland.
Perfuze is a funded company, having raised a total of $53.17M across 5 funding rounds to date.
Perfuze was founded in 2018 in Galway, Ireland, within the medical devices sector. Catheter technology has been developed for acute ischemic stroke intervention, targeting blockages in cerebral blood flow. Operations focus on healthcare innovations that address stroke-related impairments. The technology is designed to support timely treatment and minimize long-term physical disabilities in affected patients. The companys domain is perfuze.com.
Perfuze's top competitors include MicroTransponder, Conformal Medical and MIVI Neuroscience.
Perfuze offers Millipede 088 Catheter.
Perfuze has 9 investors. Key investors include EQT, European Commission, Enterprise Ireland, European Union, and Life Sciences Partners.